alpha-aminopyridine has been researched along with Venous Thromboembolism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Samkari, H; Shatzel, JJ; Wander, SA; Watson, NW | 1 |
| Al-Samkari, H; Shatzel, JJ; Watson, NW | 1 |
| Almonte, M; Charania, A; Cherlin, S; Cook, L; Cooke, G; Cooper, N; Cornelius, V; Innes, AJ; Katsarou, A; Kon, OM; Milojkovic, D; Phillips, R; Pilay, C; Shturova, T; Thursz, M; Turner, R; Vergis, N; Wason, J; Willicombe, M; Youngstein, T | 1 |
1 review(s) available for alpha-aminopyridine and Venous Thromboembolism
| Article | Year |
|---|---|
Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidence.
Topics: Aminopyridines; Anticoagulants; Breast Neoplasms; Cyclin-Dependent Kinase 4; Female; Humans; Protein Kinase Inhibitors; Pyridines; Venous Thromboembolism | 2023 |
1 trial(s) available for alpha-aminopyridine and Venous Thromboembolism
| Article | Year |
|---|---|
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
Topics: Adult; Aminopyridines; COVID-19 Drug Treatment; Humans; Morpholines; Nitriles; Oxazines; Pandemics; Pyrazoles; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Respiration, Artificial; Treatment Outcome; Venous Thromboembolism | 2021 |
1 other study(ies) available for alpha-aminopyridine and Venous Thromboembolism
| Article | Year |
|---|---|
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer.
Topics: Aminopyridines; Anticoagulants; Benzimidazoles; Breast Neoplasms; Female; Humans; Thrombosis; Venous Thromboembolism | 2022 |